![Bing Wang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: 407 Mio $ am 31.07.2026
Bing Wang is the founder of Shaanxi Mycotech Pharmaceutical Technology Co., Ltd., founded in 2007, serving as Chairman, President & Chief Executive Officer.
Former jobs include Professor at Xi'an Jiaotong University from 2001 to 2019.
Education history includes an undergraduate degree from Xi'an Jiaotong University Health Science Center in 1994, a graduate degree from Xi'an Jiaotong University in 1999, and a doctorate from Xi'an Jiaotong University in 2007.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 24.06.2026 | 66.600.000 ( 23,78 % ) | 244 Mio $ | 31.07.2026 | |
| 24.06.2026 | 44.400.000 ( 85,93 % ) | 163 Mio $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| SHAANXI MICOT PHARMACEUTICAL TECHNOLOGY CO., LTD. | Vorstandsvorsitzender | 19.01.2007 |
| Unternehmen | Position | Ende |
|---|---|---|
Xi'an Jiaotong University
 Xi'an Jiaotong University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.12.2019 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 3 |
|---|---|
Xi'an Jiaotong University
Xi'an Jiaotong University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xi'an Jiaotong University Health Science Center
 Xi'an Jiaotong University Health Science Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shaanxi Micot Technology Co., Ltd.
 Shaanxi Micot Technology Co., Ltd. BiotechnologyHealth Technology Develops drugs for the treatment of metabolic, cardiovascular and cerebrovascular diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
